UnitedHealthcare reverses policy that limited coverage of insulin pumps

UnitedHealthcare will expand what insulin pumps it considers in-network after a policy change limited which devices were covered.

JDRF, which funds Type 1 diabetes research and led a campaign calling on health insurers to expand choices for in-network Type 1 diabetes therapies, said the policy change was a "direct result of the T1D community's advocacy."

In February 2019, UnitedHealthcare expanded an existing agreement with Medtronic that denoted the devicemaker's insulin pumps preferred products for children with Type 1 diabetes. The move, which UnitedHealthcare said considered the quality and cost of the devices, effectively limited in-network options for the insulin pump from three to two.

UnitedHealthcare will now cover Tandem Diabetes insulin pumps as in-network.

More articles on payers:
Walmart to launch Medicare insurance agency
Payer execs: 5 ways COVID-19 will affect business
14 health plan deals this year

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers